...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Single-Step Assays to Analyze CYP2D6 Gene Polymorphisms in Asians: Allele Frequencies and a Novel *14B Allele in Mainland Chinese
【24h】

Single-Step Assays to Analyze CYP2D6 Gene Polymorphisms in Asians: Allele Frequencies and a Novel *14B Allele in Mainland Chinese

机译:分析亚洲人CYP2D6基因多态性的一步法:等位基因频率和中国大陆新的* 14B等位基因

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Cytochrome P450-dependent monooxygenase 2D6 (CYP2D6) activity can be estimated by investigating the metabolism of model drugs or by genotyping the most common CYP2D6 alleles. For Caucasians, the CYP2D6 allele frequencies are well investigated, and single-step assays are available for genotyping, whereas allele analysis in mainland Chinese is limited.Methods: Two tetra-primer assays and one allele-specific amplification assay were developed to easily genotype the CYP2D6 alleles *8 , *10 , and *14 previously detected in Asians. Applying these assays in combination with established single-tube assays, we analyzed 223 DNA samples from Chinese volunteers for the CYP2D6 alleles *3 , *4 , *5 , *6 , *8 , *10 , and *14 and for duplication of CYP2D6. Results: Six different alleles were detected in mainland Chinese. The most frequent mutant allele was the intermediate metabolizer allele, CYP2D6*10 , with a prevalence of 51.3%, followed by the poor metabolizer alleles CYP2D6*5 (7.2%) and a novel variant of CYP2D6*14 . This novel *14B allele (2.0%) differs from the *14 allele by the absence of the C188T substitution and by the additional G1749C substitution. Furthermore, six duplication alleles of CYP2D6 were detected, including one duplication of the *10 allele ( *10X2 ).Conclusions: The CYP2D6 allele frequencies in mainland Chinese shows some genetic diversity compared with Chinese from other regions: a novel *14B allele, a slightly higher frequency of the *5 allele, and a slightly lower frequency of the *10 allele than in most other Chinese populations.
机译:背景:细胞色素P450依赖的单加氧酶2D6(CYP2D6)活性可通过研究模型药物的代谢或对最常见的CYP2D6等位基因进行基因分型来评估。对于高加索人,已经对CYP2D6等位基因频率进行了深入研究,并且单步测定法可用于基因分型,而中国大陆的等位基因分析是有限的。方法:开发了两种四引物测定法和一种等位基因特异扩增测定法,可轻松进行基因分型先前在亚洲人中检测到的CYP2D6等位基因* 8,* 10和* 14。将这些检测方法与已建立的单管检测方法结合使用,我们分析了来自中国志愿者的223个DNA样本的CYP2D6等位基因* 3,* 4,* 5,* 6,* 8,* 10和* 14以及CYP2D6的重复。结果:在中国大陆检测到六个不同的等位基因。最常见的突变体等位基因是中间代谢者等位基因CYP2D6 * 10,患病率为51.3%,其次是弱代谢者等位基因CYP2D6 * 5(7.2%)和CYP2D6 * 14的新变异体。这个新颖的* 14B等位基因(2.0%)与* 14等位基因的不同之处在于,没有C188T取代,也没有其他G1749C取代。此外,还检测到6个CYP2D6重复等位基因,其中1个是* 10等位基因(* 10X2)的重复。结论:与其他地区的中国人相比,中国大陆人的CYP2D6等位基因频率显示出一定的遗传多样性:一个新的* 14B等位基因* 5等位基因的频率稍高,而* 10等位基因的频率比大多数其他中国人群略低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号